| Title : Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease - Chase_2017_Neurotherapeutics_14_405 |
| Author(s) : Chase TN , Farlow MR , Clarence-Smith K |
| Ref : Neurotherapeutics , 14 :405 , 2017 |
| Abstract : |
| PubMedSearch : Chase_2017_Neurotherapeutics_14_405 |
| PubMedID: 28138837 |
| Title : Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease - Chase_2017_Neurotherapeutics_14_405 |
| Author(s) : Chase TN , Farlow MR , Clarence-Smith K |
| Ref : Neurotherapeutics , 14 :405 , 2017 |
| Abstract : |
| PubMedSearch : Chase_2017_Neurotherapeutics_14_405 |
| PubMedID: 28138837 |
| Title : Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease - Chase_2017_Neurotherapeutics_14_405 |
| Author(s) : Chase TN , Farlow MR , Clarence-Smith K |
| Ref : Neurotherapeutics , 14 :405 , 2017 |
| Abstract : |
| PubMedSearch : Chase_2017_Neurotherapeutics_14_405 |
| PubMedID: 28138837 |